Novartis AG (NVS) Stock Price

NVSStock
$159.98+23.24%52W
Market Cap$304.08B
P/E20.02x
PEG Ratio3.63
Div yield3.72%
Beta1.17

NVS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-13.40%
Price vs S&P 500 (4W)-6.39%
PEG Ratio3.63
VGM Score53.18
P/E Ratio (Annual)20.02x
Indicated Dividend Yield (Annual)3.72%

NVS Earnings Surprise History

Q2 252.42est. 2.37
Q3 252.25est. 2.31
Q4 252.03est. 2.00
Q1 261.99est. 2.07
Q2 262.41est. 2.15

NVS Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.59
3.59
3.59
3.53

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
NVSNovartis AG
CCC$159.98
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85
BMYBristol-Myers Squibb Co.BBB$67.92

About Novartis AG

Novartis is a global pharmaceutical company specializing in innovative drug development across oncology, immunology, neuroscience, and respiratory/cardiovascular/metabolic diseases. It operates both an innovative medicines segment and an established medicines business with off-patent franchises. The U.S. accounts for approximately one-third of revenue, providing geographic diversification.